Why Diversity in Clinical Research Matters
When a new drug or treatment is tested in a clinical trial, the goal is to understand how it works in the real world — across different ages, genders, ethnicities, and health backgrounds. But for decades, clinical trials have enrolled populations that don't reflect the diversity of the patients they aim to help.
The Historical Gap
Studies have consistently shown that Black, Hispanic, Asian, and Indigenous populations are significantly underrepresented in clinical research. A 2020 analysis found that despite making up 13% of the U.S. population, Black Americans represented only 5% of clinical trial participants. Hispanic Americans, who make up 18% of the population, represented just 1%.
This gap has real consequences. Drug dosages, side effect profiles, and efficacy rates can vary across populations. When a treatment is tested primarily in one demographic group, we simply don't know how well it will work — or how safe it will be — for everyone else.
Why It Matters for Health Equity
Health disparities are well-documented in the DMV region and across the country. Black Americans have higher rates of cardiovascular disease, diabetes, and certain cancers. Hispanic Americans face elevated risks of diabetes and liver disease. These are precisely the populations that stand to benefit most from new treatments — and yet they are the least represented in the research that develops those treatments.
What DMV Clinical Trials Is Doing
At DMV Clinical Trials, health equity is not a talking point — it's the foundation of our mission. We have built our site network specifically to serve communities in the DC, Maryland, and Virginia region that have historically been excluded from research.
Our community outreach team builds relationships with churches, community health centers, and advocacy organizations. We offer transportation assistance, flexible scheduling, and multilingual staff. We conduct our informed consent process in plain language, and we never pressure anyone to participate.
We believe that when research reflects the full diversity of humanity, the treatments that emerge from that research will be better for everyone.
